Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Direct ✕Axis ESG Integration Strategy Fund · Direct ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseHDFCAxis
NAV₹23.6750₹22.8900
NAV date20 Nov 202620 Nov 2026
History3.1 years6.8 years
Expense ratio1.1%1.8%
Stars★★★★★★★★★★
Growth Score94.5027.80

Returns

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
1 month+12.97%+6.66%
3 months+7.13%−0.17%
6 months+17.84%+4.33%
YTD+33.73%−3.13%
1 year+32.20%−3.09%
3 years (CAGR)+30.70%+8.47%
5 years (CAGR)—+5.41%
10 years (CAGR)——
Since launch+31.83%+12.87%

Risk

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
Volatility15.8%14.1%
Downside volatility8.5%10.3%
Sharpe1.530.14
Sortino2.860.19
Calmar2.060.48
Return / risk1.950.60
Deepest fall−14.91%−24.30%
Days to recover126517
Below its high+0.00%−7.66%

Against benchmark

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
Alpha+7.54%—
Beta0.97—
R²85.0%—
Up capture108.9%—
Down capture71.0%—
Tracking error6.1%—
Information ratio1.17—
Treynor0.24—

Consistency

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
Best 1-year+67.01%+70.80%
Middle 1-year+23.25%+9.41%
Worst 1-year+1.71%−16.36%
1-year periods with a loss0.0%28.8%
Middle 3-year+30.22%+13.11%
Positive months72.2%63.9%
Best day+3.18%+3.71%
Worst day−3.61%−3.53%
Worst 5% day−1.51%−1.22%
Positive days58.3%52.6%
NAVs a year247251

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundAxis ESG Integration Strategy Fund
5-year XIRR—+7.32%
5-year value—₹7,24,420
3-year XIRR+27.71%+3.16%
1-year XIRR+41.37%+2.79%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth